Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago’s Pritzker School of Molecular Engineering (PME) have developed
The article has the link to the original paper published in Nature Biomedical engineering at the bottom.
Thanks!
Hm, well the full paper is behind a subscription wall but the abstract sounds much more modest:
Our findings show that pGal–antigen therapy invokes mechanisms of immune tolerance to resolve antigen-specific inflammatory T-cell responses and suggest that the therapy may be applicable across autoimmune diseases.
“May be applicable” —> “can completely reverse” ???
